Literature DB >> 16795113

Bone marrow and tumour stroma: an intimate relationship.

Natalie C Direkze1, Malcolm R Alison.   

Abstract

In recent years the bone marrow has become recognized as a potential source of cells for non-haematopoietic wound healing, in some instances demonstrating surprising plasticity in providing new epithelial cells. On the other hand, the contribution of bone marrow derived cells to fibrosis and blood vessel formation is more widely acknowledged. Tumour stroma has a vital role to play in determining cancer growth and spread, and there is a growing realization that the bone marrow has a significant input into this desmoplastic response. This review focuses on the contribution of bone marrow cells to tumour stroma, highlighting the bone marrow as a potential new portal through which to direct anti-tumour therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16795113     DOI: 10.1002/hon.788

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  16 in total

1.  Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival.

Authors:  Haruhisa Kitano; Shun-Ichiro Kageyama; Stephen M Hewitt; Ryuji Hayashi; Yoshinori Doki; Yoshitomo Ozaki; Shozo Fujino; Mikiko Takikita; Hajime Kubo; Junya Fukuoka
Journal:  Arch Pathol Lab Med       Date:  2010-10       Impact factor: 5.534

2.  Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma.

Authors:  J Humberto Treviño-Villarreal; Douglas A Cotanche; Rosalinda Sepúlveda; Magda E Bortoni; Otto Manneberg; Taturo Udagawa; Rick A Rogers
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

Review 3.  Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease.

Authors:  Juanita L Merchant
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 4.  Mechanisms of malignant progression.

Authors:  Robert A Weinberg
Journal:  Carcinogenesis       Date:  2008-05-02       Impact factor: 4.944

Review 5.  Mesenchymal stem cells as vectors for lung disease.

Authors:  Michael R Loebinger; Elizabeth K Sage; Sam M Janes
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

Review 6.  Fibroblasts as architects of cancer pathogenesis.

Authors:  Timothy Marsh; Kristian Pietras; Sandra S McAllister
Journal:  Biochim Biophys Acta       Date:  2012-10-30

7.  Transcription factor ATF3 links host adaptive response to breast cancer metastasis.

Authors:  Chris C Wolford; Stephen J McConoughey; Swati P Jalgaonkar; Marino Leon; Anand S Merchant; Johnna L Dominick; Xin Yin; Yiseok Chang; Erik J Zmuda; Sandra A O'Toole; Ewan K A Millar; Stephanie L Roller; Charles L Shapiro; Michael C Ostrowski; Robert L Sutherland; Tsonwin Hai
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

8.  Systemic endocrine instigation of indolent tumor growth requires osteopontin.

Authors:  Sandra S McAllister; Ann M Gifford; Ashley L Greiner; Stephen P Kelleher; Matthew P Saelzler; Tan A Ince; Ferenc Reinhardt; Lyndsay N Harris; Bonnie L Hylander; Elizabeth A Repasky; Robert A Weinberg
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

9.  Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.

Authors:  Felipe Saldanha-Araujo; Rodrigo Haddad; Kelen C R Malmegrim de Farias; Alessandra de Paula Alves Souza; Patrícia V Palma; Amélia G Araujo; Maristela D Orellana; Julio C Voltarelli; Dimas T Covas; Marco A Zago; Rodrigo A Panepucci
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

Review 10.  Cancer associated fibroblasts (CAFs) in tumor microenvironment.

Authors:  Fei Xing; Jamila Saidou; Kounosuke Watabe
Journal:  Front Biosci (Landmark Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.